NCT06506825

Brief Summary

This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
56mo left

Started Aug 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Aug 2024Dec 2030

First Submitted

Initial submission to the registry

July 12, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

July 18, 2024

Status Verified

July 1, 2024

Enrollment Period

6.4 years

First QC Date

July 12, 2024

Last Update Submit

July 12, 2024

Conditions

The Study Focuses on Gastric Cancer

Outcome Measures

Primary Outcomes (1)

  • 5-year overall survival

    5-year overall survival

    2025-12-31

Secondary Outcomes (1)

  • 5-year recurrence-free survival

    2025-12-31

Interventions

Gastric Cancer AI-driven Data Integration Genomic Analysis BiomarkerDIAGNOSTIC_TEST

Enter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with gastric cancer

You may qualify if:

  • All patients with gastric cancer

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General Surgery

Shijiazhuang, Hebei, 050011, China

RECRUITING

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 12, 2024

First Posted

July 18, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

July 18, 2024

Record last verified: 2024-07

Locations

CN(1)